AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius Medical Care AG & Co. KGaA

Transaction in Own Shares Jun 4, 2018

165_rns_2018-06-04_14d7004c-1152-46d5-9c36-aec9efa7d89a.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

News Details

Other Capital Market Information | 4 June 2018 17:07

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para.
1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052

04.06.2018 / 17:07
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


  • Share buy-back - 1st Interim Report

In the period from 28 May 2018 until and including 1st June 2018, a total
of 217,774 shares were repurchased within the framework of the share buy-
back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical
Care'), which was announced on 25 May 2018 pursuant to Art. 5 para. 1 lit.
a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated
Regulation (EU) 2016/1052.

Day of repurchase Aggregated volume in Weighted average share
number of shares price in EUR
28 May 2018 43,274 86.8348
29 May 2018 43,500 86.4675
30 May 2018 43,500 87.0162
31 May 2018 43,000 86.3560
01 June 2018 44,500 85.1607

The total volume of shares repurchased within the framework of this share
buy-back in the period from 28 May 2018 until and including 217,774 June
2018 therefore amounts to 217,774 shares.

The purchase of shares of Fresenius Medical Care within the framework of
the share buy-back programme was carried out exclusively on the Frankfurt
Stock Exchange via the XETRA trading platform by a credit institution
commissioned by Fresenius Medical Care.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical
Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., 4 June 2018


04.06.2018 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de


 Language:    English
 Company:     Fresenius Medical Care AG & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg
              Germany
 Internet:    www.freseniusmedicalcare.com



 End of News    DGAP News Service

Talk to a Data Expert

Have a question? We'll get back to you promptly.